Biniam Kidane: The IASLC Grant is Pivotal Step Toward Advancing My Translational Lung Cancer Research
International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“ ‘This grant will provide critical seed funding to build on and validate the promising results my translational research team generated in my early career. With prior early-career support, we developed both human and experimental in vivo models to study treatment-induced inflammation and its role in early cancer recurrence. My goal is to expand this work into a large, multi-center translational study using an iterative bench-to-bedside-to-bench approach. However, to reach that stage, we first need transitional funding to refine and confirm our models as essential groundwork. The IASLC grant is a pivotal step toward bringing this vision to reality.’
— Paraphrased from Biniam Kidane, MD MSc
Ready to take your research to the next level? The next round of IASLC Mid-Career Grant applications opens soon.”
More posts featuring International Association for the Study of Lung Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023